Allergan pays $750m to avoid Alzheimer’s drug lawsuit

Allergan pays $750m to avoid Alzheimer’s drug lawsuit

Source: 
Pharmaforum
snippet: 

Allergan has agreed to pay $750 million to settle lawsuits in the US brought by direct purchasers of its Namenda Alzheimer’s drug in the US.